the aid library

Access to medicines: making market forces serve the poor

World Health Organization WHO (2017) C_WHO

The successful COVID-19 vaccine rollout in Chile: Factors and challenges

Castillo C., Villalobos Dintrans P. et al (2021) C2

The aim of this article is to identify the elements behind the country’s successful COVID-19 rollout as well as lessons and chal lenges derived from this process. The analysis is relevant to many countries today—as they keep searching for strategies to cope with the second year of the COVID-19 p ... more

A double dose of inequality; Pharma companies and the Covid-19 vaccines crisis

Amnesty International (2022) C2

22 Sept. 2021 The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi ... more

Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance

World Health Organization WHO (2021) C_WHO

An Action Framework and annexe to Immunization Agenda 2030 (Draft version) 27 January 2021

Syrian Arab Republic: COVID-19 Humanitarian Update No. 25 as of 10 June 2021

Office for the Coordination of Humanitarian Affairs OCHA (2021) C1

Plano Nacional de operacionalizacao da vacincao contra a COVID-19 (National Plan for the operationalization on vaccination against COVID-19)
recommended

Ministerio da Saude do Brasil Ministerio da Saude do Brasil (2021) CC

Este plano apresenta diretrizes gerais para a Campanha Nacional de Vacinação contra a Covid-19, de forma que especificidades e alterações de cenários conforme disponibilidade de vacinas serão informadas e divulgadas por meio de Informes Técnicos da Campanha Nacional de Vacinação, divulgados ... more

COVID-19 Vaccine Roll Outs in ASEAN & Asia – Live Updates by Country

Asean Briefing (2021) CC

It will be updated continuously. Details of COVID-19 availability in all ten ASEAN countries and another 30 Asian nations. Due to the developing situation in China and Asia concerning the Coronavirus, we will be operating this article as a running live update service to keep businesses involved in ... more

Job aid for COVID-19 vaccine administration: AZD1222 (‎ChAdOx1-S [‎recombinant]‎)‎ COVID-19 vaccine

World Health Organization WHO, Regional Office of Europe (2021) C_WHO

Responding to COVID-19 in Africa: using data to find a balance part III

African Union, African CDC, World Health Organisation (2021) C_WHO

12 May 2021. This third survey in the series shows that the COVID-19 pandemic continues to impact societies, not only in terms of health, but also social and economic conditions and day-to-day life

Promoting access to medical technologies and innovation, second edition, 30 August 2021

World Health Organization WHO and World Intellectual Property Organization WTO, WHO, WIPO (2021) CC

The second edition of the joint WHO, WIPO and WTO publication “Promoting Access to Medical Technologies and Innovation: Intersections between public health, intellectual property and trade” (the Trilateral Study),* published in 2020, included a special insert mappi ... more

Sarampión: una enfermedad re emergente en Venezuela

Ana Carvajal, José Félix Oletta López, Alejandro Rísquez Sociedad Venezolana de Salud Pública (2017) C1

Dengue virus: epidemiology, biology, and disease aetiology

Kumar Roy., S. and S. Bhattacharjee (2021) CC

Canadian Journal of Microbiology 25 June 2021 https://doi.org/10.1139/cjm-2020-0572

Antibiotic Regimens in meningitis epidemics in sub-Saharan Africa

L. Cibrelus World Health Organization (2014) C_WHO

Report for the WHO Meningitis Guideline Revision (May 2014)

Review of Tuberculosis Prevention, Control and Care in Azerbaijan (Russian edition)

M. Dara, O. Gozalov, O. Javadli, et al. World Health Organization Europe (2013) C_WHO

11-17 April 2012 Оценка профилактики и борьбы с туберкулезом и противотуберкулезной помощи в Азербайджане 11–17 апреля 2012 г.

Protection from a Single Dose of HPV Vaccine A major public health impact from IARC studies of vaccine efficacy

World Health Organisation (WHO) (2023) C_WHO

Protection from a Single Dose of HPV Vaccine A major public health impact from IARC studies of vaccine efficacy.

Interregional workshop for tuberculosis control and care among refugees and migrant populations

World Health Organization Europe (2016) C_WHO

10–11 May 2016, Catania, Italy

Cardiovascular risk in Mozambique: who should be treated for hypertension?

Damasceno, A; Padrão P; Silva-Matos, C; et al (2014) C1

This study aimed to estimate the proportion of Mozambicans eligible for pharmacological treatment for hypertension according to single risk factor and total cardiovascular risk approaches. It concluded that a total of 19.8% of 40–64-year-olds would be eligible for pharmacological treatment of hype ... more

CONSENSUS DOCUMENT FOR MANAGEMENT OF Non Hodgkin’s Lymphoma (High Grade)

Indian Council of Medical Research (ICMR) (2016) C1

Prepared as an outcome of ICMR Subcommittee on Non Hodgkin’s Lymphoma (High Grade) | This consensus document on management of non- hodgkin’s lymphoma – high grade summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molec ... more